CorMedix

$CorMedix(CRMD)$ 谁来挖掘下，貌似不错。这个比VOR降低一个难度。

$CorMedix(CRMD)$ 144 Report of proposed sale of securities Accession Number: 0001628280-25-050229  Act: 33  Size: 4 KB 网页链接

$CorMedix(CRMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-25-115725  Size: 19 KB 网页链接

$CorMedix(CRMD)$ 144 Report of proposed sale of securities Accession Number: 0001628280-25-056128  Act: 33  Size: 5 KB 网页链接

$CorMedix(CRMD)$ RW Registration Withdrawal Request Accession Number: 0001213900-25-096229  Act: NE  Size: 6 KB 网页链接

$CorMedix(CRMD)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-005229  Act: 34  Size: 11 KB 网页链接

$CorMedix(CRMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-25-120296  Size: 6 KB 网页链接

$CorMedix(CRMD)$ 144 Report of proposed sale of securities Accession Number: 0001959173-25-007601  Act: 33  Size: 20 KB 网页链接

$CorMedix(CRMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-25-120378  Size: 12 KB 网页链接

$CorMedix(CRMD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-25-100156  Act: 34  Size: 235 KB 网页链接

$CorMedix(CRMD)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-25-101906  Act: 34  Size: 3 MB 网页链接

$CorMedix(CRMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-25-118433  Size: 15 KB 网页链接

$CorMedix(CRMD)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-25-108777  Act: 34  Size: 8 MB 网页链接

$CorMedix(CRMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-25-112316  Size: 4 KB 网页链接

$CorMedix(CRMD)$ 144 Report of proposed sale of securities Accession Number: 0001628280-25-053802  Act: 33  Size: 4 KB 网页链接

$海普瑞(SZ002399)$ DefenCath是美国FDA于2023年新批准上市的，目前唯一用于肾衰透析治疗防血流感染（CRBSI）的药物。其成分由牛磺罗定和肝素构成。Cormedix公司是DefenCath的研发和生产商。该公司主要业务就是生产销售这种药物。Defencath自2023年推出美国市场以来，增长强劲。Coremedix公司于202...

$CorMedix(CRMD)$ 144 Report of proposed sale of securities Accession Number: 0001628280-25-057973  Act: 33  Size: 4 KB 网页链接

$CorMedix(CRMD)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001213900-25-094067  Act: 33  Size: 466 KB 网页链接

$CorMedix(CRMD)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0001213900-25-093983  Act: 34  Size: 1 MB 网页链接

$CorMedix(CRMD)$ PRER14A Preliminary Proxy Soliciting materials Accession Number: 0001213900-25-098867  Act: 34  Size: 3 MB 网页链接